It’s been a busy travel month for me, meeting with research leaders, policy-makers, funders, collaborators and with TDR alumni. All are important for making a difference and I learn something with each encounter. Our hope is that many TDR grantees someday become leaders to help shape research priorities and processes and this month you can read more about one of the stars who is doing just that.
A TDR alumni profileIn East Timor, a TDR alumnus is laying the foundations for a healthier future. Long before he was the Minister of Health of the Democratic Republic of East Timor, Dr Nélson Martins served as a physician to his fellow countrymen as they fought for independence from Indonesian rule. He went on to conduct important research in TB with TDR support, and also extended the reach of basic primary health care to the poor in remote rural communities by mobilizing cadres of volunteer health workers.
A new integrated research and training programme for public health workers is helping countries use their data to reduce multi-drug resistant TB and a host of other challenges. Find out more with this profile on a recent workshop in Estonia.
The second of three workshops to pilot the new TDR implementation research tool kit was held in Dhaka, Bangladesh 22-26 September. Twenty-eight participants from Bangladesh, the People’s Republic of China, Indonesia, Malaysia Nepal, Nigeria, Pakistan and Sri Lanka recently completed a test of the new TDR implementation research toolkit. The toolkit is designed to help researchers identify bottlenecks that limit effective delivery and access to medical interventions for those in need of them.
8 November 2013
Early results from a clinical drug trial of a new 4-month treatment for tuberculosis (TB) indicate that it is well tolerated, but overall could not be considered as an alternative to current 6-month standard treatment. The study was presented at the 44th Union World Conference on Lung Health in Paris on 3 November by researchers from the London School of Hygiene & Tropical Medicine on behalf of the Gatifloxacin for TB team.
30 October 2013
The 44th Union World Conference on Lung Health will be held 30 October – 3 November 2013 in Paris. This is the conference of the International Union Against Tuberculosis and Lung Disease, and TDR is involved in several events before and during this annual conference that draws together 2500 delegates from 125 countries.
25 October 2013
A rigorous assessment of drug and vaccine development for neglected diseases that shows some improvement over the last decade but still major gaps has been published in the Lancet today. Only 4% of the new therapeutic products registered between 2000-11 were for 11% of the global disease burden, and only 4 new chemical entities that can lead to truly new products were approved.